In vitro and in vivo properties of a dimeric bispecific single-chain antibody IgG-fusion protein for depletion of CCR2(+) target cells in mice

Schneider, M. A. and Bruehl, H. and Wechselberger, A. and Cihak, J. and Stangassinger, M. and Schloendorff, D. and Mack, Matthias (2005) In vitro and in vivo properties of a dimeric bispecific single-chain antibody IgG-fusion protein for depletion of CCR2(+) target cells in mice. EUROPEAN JOURNAL OF IMMUNOLOGY, 35 (3). pp. 987-995. ISSN 0014-2980, 1521-4141

Full text not available from this repository. (Request a copy)

Abstract

The chemokine receptor CCR2 is highly expressed on leukocytes in several inflammatory diseases of both mice and men. Apart from blockade of CCR2 to prevent chemokine-dependent cell migration, depletion of CCR2(+) cells might be a promising strategy for treatment of inflammatory diseases. We therefore designed a bispecific antibody construct with the ability to deplete CCR2(+) target cells in vitro and in vivo. The bispecific antibody construct consists of two single-chain antibody variable fragments (scFv) - one recognizing murine CD3 epsilon and the other recognizing murine CCR2 -joined by a short linker and fused to a modified hinge region and the C(H)2 and C(H)3 domains of murine IgG1 for dimerization. The protein was expressed in mammalian cells and purified via its C-terminal histidine tail. In vitro this construct leads to efficient antigen specific and costimulation-independent activation of T cells and strong lysis of CCR2(+) target cells. In vivo the construct induces an almost complete depletion of CCR2(+)CD11b(+) monocytes from the peripheral blood and spleens of BALB/c mice within 24 h. This recombinant protein construct is a dimeric, bispecific antibody with markedly improved serum levels compared to conventional bispecific single-chain antibodies and the ability to deplete CCR2(+)CD11b(+) monocytes in vivo.

Item Type: Article
Uncontrolled Keywords: RENAL-TRANSPLANT REJECTION; CHEMOKINE RECEPTORS; TANDEM DIABODY; CC-CHEMOKINE; T-CELLS; EXPRESSION; CYTOTOXICITY; ARTHRITIS; DISEASES; PHARMACOKINETICS; bispecific single-chain antibody; antibody engineering; chemokine receptor; CCR2; cell depletion
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Dr. Gernot Deinzer
Date Deposited: 18 May 2021 10:44
Last Modified: 18 May 2021 10:44
URI: https://pred.uni-regensburg.de/id/eprint/36404

Actions (login required)

View Item View Item